FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel derivatives of N-(3-piperidinylcarbonyl)-beta-alanine of the general formula (I) where R1 means piperidinyl that can has amino-protective group; R2 means carboxy- or esterified carboxy-group; A1 means C1-C6-alkylene, C1-C6-alkanyl-idene; A2 means C1-C6-alkylene; A3 means C1-C6-alkylene that can has a single suitable substituent taken among the group including C1-C6-alkyl, C2-C6-alkenyl, C1-C6-alkynyl, cyano-, amino- -group, protected aminoacyl-group, C1-C6-alkylsulfonylamino- -C1-C6-alkyl, phenyl, phenyl-C1-C6-alkynyl, phenyl-C1-C6alkyl substituted with from 1 to 4 C1-C6-alkoxy-groups, halogen-C1-C6- alkyl, C1-C6-alkylenedioxy, C1-C6-alkyl substituted with unsaturated condensed 5-6-membered heterocyclic group containing from 1 to 4 nitrogen atoms, phenylsulfonyl-C1-C6- -alkyl and unsaturated 5-6-membered heterocyclic group containing from 1 to 4 nitrogen atoms; is the group where means piperidyl, tetrahydroquinolyl, pyrrolidinyl or morpholinyl; X means O or NH; Y means NH; Z means the group (a) where R3 is hydrogen atom or C1-C6-alkyl; l = 0 or 1; m = 0 or 1; n = 0 or 1, or its pharmaceutically acceptable salt. Novel compounds are antagonists of glyco-protein IIb/IIIa, inhibitors of platelet aggregation and inhibitors of binding fibrinogen with platelets. Invention describes also method of synthesis of proposed compounds, pharmaceutical preparation containing this compound and method of prophylaxis and/or treatment of patients or animals with diseases given in the description of invention. EFFECT: new compounds indicated above, improved method of synthesis, valuable medicinal properties. 32 cl, 1 tbl, 44 ex
Title |
Year |
Author |
Number |
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Khidenori Oki
- Masaki Tomisima
- Akira Jamada
- Khizasi Takazugi
|
RU2165423C2 |
AMIDINONAPHTYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION |
1995 |
- Khirajama Fukusi
- Kosio Khirojuki
- Matsumoto Juzo
- Kavasaki Tomikhisa
- Kaku Sejdzi
- Janagisava Isao
|
RU2154633C2 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1993 |
- Juiti Siokava
- Masanobu Nagano
- Kijosi Taniguti
- Kazukhiko Take
- Takesi Kato
- Kazunori Tsubaki
|
RU2125983C1 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS |
1994 |
- Taniguti Kiesi
- Nagano Masanobu
- Khattori Kojudzi
- Tsubaki Kazunori
- Okitsu Osamu
- Tabuti Sejitiro
|
RU2176640C2 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1990 |
- Matsuo Masaaki[Jp]
- Tsudzi Kiesi[Jp]
- Konisi Nobukie[Jp]
- Nakamura Katsuja[Jp]
|
RU2021990C1 |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
- Masaaki Matsuo
- Kijosi Tsudzi
- Takasi Ogino
- Nobukijo Konisi
|
RU2128172C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT |
1993 |
- Masaaki Matsuo
- Dajdzhiro Khagivara
- Khirosi Mijake
|
RU2119922C1 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS |
1994 |
- Atsusi Kuno
- Josikazu Inou
- Khisasi Takasugi
- Khiroaki Mizuno
- Kumi Jamasaki
|
RU2141946C1 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Norikhiko Simazaki
- Sinja Vatanabe
- Akikhiko Savada
- Kejdzi Khemmi
|
RU2170737C2 |